HUDSON, N.Y., Aug. 23, 2017 -- Taconic Biosciences announces plans to move its corporate headquarters up the Hudson River from Hudson to the Albany, NY area at the end of 2017. The new location is near several existing Taconic facilities in Rensselaer, 45 miles from its primary operations facility in Germantown, NY, and accessible to all global locations.
With Taconic’s increasing prominence within the global pharmaceutical industry, the location of the new headquarters will provide a more convenient venue for key stakeholders and customers, provide access to highly-skilled talent, and puts Taconic in the center of the booming Albany technology hub. The new facility will house the company’s leadership team, as well as members of its product strategy, marketing, human resources, finance, quality, customer service, and business technology teams. 35 jobs will relocate to the Albany area, while 28 will move to the Germantown facility. “Relocating Taconic’s headquarters to the Health Sciences Campus expands on a long-standing relationship between the two organizations. The resulting co-location of more than 130 Taconic employees will increase internal collaboration across functions. The site’s easily accessible location to highly educated talent, as well as proximity to prospective partners and customers, makes it an ideal fit,” shared David Lester, senior vice president of human resources and organization development.
Located on the Albany Health Sciences Campus in Rensselaer, NY, the new corporate headquarters will be in the state-of-the-art Cancer Research Center building, which already houses Taconic’s molecular analysis laboratory. The site is home to other key players within the pharmaceutical industry, notably Regeneron, Albany Molecular Research, Inc., Albany Medical College, Albany College of Pharmacy, and several other biomedical organizations. Taconic also occupies two other buildings on the campus, housing its scientific services business and operations functions. “We are pleased to expand our relationship with Taconic and bring additional jobs to the UABDC property,” expressed Richard P. McGinn Jr, executive director at the University at Albany Bioscience Development Corporation.
The address of the Cancer Research Center building on the Albany Health Campus is:
1 Discovery Drive
Rensselaer, NY 12144
With over six decades of animal model experience, Taconic Biosciences leveraged its strong roots in the Hudson Valley to build an international organization that is recognized as a global leader in in biomedical research.
To learn more about Taconic Biosciences, please call 1-888-TACONIC (888-822-6642) in the US, or +45 70 23 04 05 in Europe, or email [email protected].
About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology companies and institutions acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Media Contact: Kelly Owen Grover Director of Marketing Communications (518) 697-3824


TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Instagram Outage Disrupts Thousands of U.S. Users
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins 



